Back to company

LICA PHARMACEUTICALS ApS: Financial statements 2020

CVR: 25332520

LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 326,213 and a net result of DKK 843,617 compared with DKK 2,782,288 the year before. That is an increase of 16.6% compared with the year before. Equity amounted to DKK 19,593,671. The solvency ratio was 99.3%.

Gross Profit
326,213 kr.
Profit/Loss
843,617 kr.
Equity
19,593,671 kr.
Total Assets
19,737,400 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-326 t.844 t.19.6 mio.0
2019-280 t.2.8 mio.18.8 mio.-
2018-973 t.5.6 mio.18.4 mio.-
2017-409 t.812 t.12.8 mio.-
2016-738 t.328 t.12 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is LICA PHARMACEUTICALS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

LICA PHARMACEUTICALS ApS appoints new auditorDec 31, 2020

As of December 31, 2020, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of LICA PHARMACEUTICALS ApS.

Auditor steps down at LICA PHARMACEUTICALS ApSDec 31, 2020

As of December 31, 2020, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of LICA PHARMACEUTICALS ApS.

LICA PHARMACEUTICALS ApS: The 2019 annual report is outApr 2, 2020

LICA PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK 279,654, and the net result was DKK 2,782,288.

About LICA PHARMACEUTICALS ApS

LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.